338 related articles for article (PubMed ID: 23825314)
1. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with lymphotoxin β-producing dendritic cells in human breast cancer.
Martinet L; Filleron T; Le Guellec S; Rochaix P; Garrido I; Girard JP
J Immunol; 2013 Aug; 191(4):2001-8. PubMed ID: 23825314
[TBL] [Abstract][Full Text] [Related]
2. Human solid tumors contain high endothelial venules: association with T- and B-lymphocyte infiltration and favorable prognosis in breast cancer.
Martinet L; Garrido I; Filleron T; Le Guellec S; Bellard E; Fournie JJ; Rochaix P; Girard JP
Cancer Res; 2011 Sep; 71(17):5678-87. PubMed ID: 21846823
[TBL] [Abstract][Full Text] [Related]
3. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.
Martinet L; Le Guellec S; Filleron T; Lamant L; Meyer N; Rochaix P; Garrido I; Girard JP
Oncoimmunology; 2012 Sep; 1(6):829-839. PubMed ID: 23162750
[TBL] [Abstract][Full Text] [Related]
4. Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.
Colbeck EJ; Jones E; Hindley JP; Smart K; Schulz R; Browne M; Cutting S; Williams A; Parry L; Godkin A; Ware CF; Ager A; Gallimore A
Cancer Immunol Res; 2017 Nov; 5(11):1005-1015. PubMed ID: 28947544
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of immune infiltrates in breast ductal carcinoma in situ.
Chen XY; Yeong J; Thike AA; Bay BH; Tan PH
Breast Cancer Res Treat; 2019 Aug; 177(1):17-27. PubMed ID: 31134489
[TBL] [Abstract][Full Text] [Related]
6. High endothelial venules in intracranial germinomas: Implications for lymphocytes infiltration.
Chen H; Li G; Cui Y; Zhang Q; Li B; Liu X
Cancer Med; 2023 Mar; 12(5):5450-5460. PubMed ID: 36259639
[TBL] [Abstract][Full Text] [Related]
7. Understanding high endothelial venules: Lessons for cancer immunology.
Ager A; May MJ
Oncoimmunology; 2015 Jun; 4(6):e1008791. PubMed ID: 26155419
[TBL] [Abstract][Full Text] [Related]
8. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
10. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
[TBL] [Abstract][Full Text] [Related]
11. Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients.
Chan MS; Chen SF; Felizola SJ; Wang L; Nemoto N; Tamaki K; Ishida T; Chow LW; Ohuchi N; Sasano H
Int J Biol Markers; 2014 Sep; 29(3):e193-203. PubMed ID: 24803281
[TBL] [Abstract][Full Text] [Related]
12. Role of CXCL10 in the progression of in situ to invasive carcinoma of the breast.
Kim M; Choi HY; Woo JW; Chung YR; Park SY
Sci Rep; 2021 Sep; 11(1):18007. PubMed ID: 34504204
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor-infiltrating LAMP-3 dendritic cells on the prognosis of esophageal squamous cell carcinoma.
Nishimura J; Tanaka H; Yamakoshi Y; Hiramatsu S; Tamura T; Toyokawa T; Muguruma K; Maeda K; Hirakawa K; Ohira M
Esophagus; 2019 Oct; 16(4):333-344. PubMed ID: 30968254
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis in Lymph Nodes Is a Critical Regulator of Immune Response and Lymphoma Growth.
Menzel L; Höpken UE; Rehm A
Front Immunol; 2020; 11():591741. PubMed ID: 33343570
[TBL] [Abstract][Full Text] [Related]
15. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
16. Mature dendritic cells correlate with favorable immune infiltrate and improved prognosis in ovarian carcinoma patients.
Truxova I; Kasikova L; Hensler M; Skapa P; Laco J; Pecen L; Belicova L; Praznovec I; Halaska MJ; Brtnicky T; Salkova E; Rob L; Kodet R; Goc J; Sautes-Fridman C; Fridman WH; Ryska A; Galluzzi L; Spisek R; Fucikova J
J Immunother Cancer; 2018 Dec; 6(1):139. PubMed ID: 30526667
[TBL] [Abstract][Full Text] [Related]
17. Immune microenvironment in ductal carcinoma in situ: a comparison with invasive carcinoma of the breast.
Kim M; Chung YR; Kim HJ; Woo JW; Ahn S; Park SY
Breast Cancer Res; 2020 Mar; 22(1):32. PubMed ID: 32216826
[TBL] [Abstract][Full Text] [Related]
18. Regulation of tumor-associated high-endothelial venules by dendritic cells: A new opportunity to promote lymphocyte infiltration into breast cancer?
Martinet L; Girard JP
Oncoimmunology; 2013 Nov; 2(11):e26470. PubMed ID: 24482745
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
[TBL] [Abstract][Full Text] [Related]
20. The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous melanoma.
Avram G; Sánchez-Sendra B; Martín JM; Terrádez L; Ramos D; Monteagudo C
Histopathology; 2013 Dec; 63(6):852-61. PubMed ID: 24102908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
